CCL2 and Alzheimer disease: Recently, Schipke and colleagues proposed the combined measurement of six different blood markers, BDNF, IGF-1, VEGF, TGF-beta 1, MCP-1 and IL-18 to identify Alzheimer’s disease patients [31].